Dialysis provider DaVita Inc. (NYSE: DVA) will be reporting results this Tuesday after market hours. Here’s what you need to know.
DaVita beat analysts’ revenue expectations last quarter, reporting revenues of $3.62 billion, up 9.9% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ full-year EPS guidance estimates and a solid beat of analysts’ revenue estimates.
Is DaVita a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting DaVita’s revenue to grow 3.8% year on year, slowing from the 5% increase it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. DaVita rarely misses Wall Street’s revenue estimates.
Looking at DaVita’s peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Encompass Health delivered year-on-year revenue growth of 9%, beating analysts’ expectations by 1.2%, and Select Medical reported revenues up 5%, topping estimates by 0.9%. Encompass Health traded up 7.5% following the results while Select Medical’s stock price was unchanged.
Read our full analysis of Encompass Health’s results here and Select Medical’s results here.
There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 6% on average over the last month. DaVita’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $151.71 (compared to the current share price of $151.55).
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
